Dr.Lise Gehrt Cardél has led a groundbreaking study that sheds new light on the broader health benefits of the measles-mumps-rubella (MMR) vaccine. This large-scale, nationwide cohort study across Denmark, Finland, Norway, and Sweden found that children who received MMR after the diphtheria-tetanus-acellular pertussis (DTaP) vaccine had lower rates of infectious disease hospitalizations, suggesting potential non-specific protective effects beyond its targeted diseases.
This achievement would not have been possible without the dedication of Dr. Gehrt and an exceptional team of researchers, clinicians, and public health experts who contributed their expertise and commitment. Their work provides crucial evidence supporting the need for further randomized trials to better understand the broader health impacts of childhood vaccines.
